Used as a key intermediate in Suzuki-Miyaura cross-coupling reactions for the synthesis of biologically active compounds, particularly in pharmaceutical and agrochemical research. Its boronate ester group enables efficient carbon-carbon bond formation, making it valuable in constructing complex heterocyclic systems found in drug candidates. Commonly employed in the development of kinase inhibitors and other targeted therapies due to the pyrrolopyridine scaffold’s favorable binding properties with biological targets.